Search For "cova"
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials, say s
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Read More
DCGI's expert panel to review Phase III data of Covaxin today
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 8 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
India to favour discussions on 'vaccine passports' with greater focus on v
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): While countries like Japan deciding to issue "vaccine passports" as proof of immunisation for its citizens travelling abroad, India on Thursday said that it will favour discussion with a greater focus on vaccine equity, since many developing nations are y
Read More
Novavax's COVID-19 vaccine 'Covavax' to launch in India by September: Sour
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the COVID-19 vaccine - 'Covavax' by September this year and start trials on children from July.
Read More
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin.
Read More
No quarantine for Covishield vaccinated Indians in South Korea, mandatory
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): Indians vaccinated with double doses of the Covishield vaccine will be able to enter South Korea freely as South Korea is going to withdraw the mandatory two-week quarantine guidelines from July 1. However, those inoculated with Covaxin will have to remai
Read More
Patra attacks Congress, accuses it of creating doubts about Covaxin
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): BJP leader Sambit Patra on Wednesday attacked the Congress over remarks of its national social media coordinator concerning the manufacturing process of Covaxin based on RTI response and said the opposition party will be remembered for "creating doubts ab
Read More
Covid-19: No newborn calf serum in final Covaxin product, says Health mini
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): The Union Health Ministry on Wednesday said that newborn calf serum is not an ingredient of the final Covaxin vaccine by Bharat Biotech.
Read More
Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 15 (ANI): Indigenous COVID-19 vaccine maker Bharat Biotech on Tuesday said the supply price of Covaxin to the Government of India at Rs 150 per dose is a non-competitive price and not sustainable in the long run, hence a higher price in private markets is
Read More
COVID-19: Owaisi targets Centre over official death toll, raises question
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 15 (ANI): Alleging that India's death toll due to COVID is 'five to six' times more than the official data, All India Majlis-e-Ittehadul Muslimeen (AIMIM) chief Asaduddin Owaisi said that the Central government has "no touch with the reality".
Read More
AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials f
Updated : 4 years, 9 months ago IST
New Delhi [India], June 14 (ANI): The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.
Read More